‘Game-changing' Alzheimer's drug could STOP disease in its tracks – as the ‘most powerful weapon' against condition yet
Click to share on Facebook (Opens in new window)
A NEW "game-changing" drug could stop the progression of Alzheimer's disease, early trials suggest.
Scientists say the treatment - called trontinemab - could be the most powerful weapon yet against dementia, as they look into giving the drug to people with no symptoms in the hopes of preventing disease.
Sign up for Scottish Sun
newsletter
Sign up
1
Trontinemab is formulated to bypass the blood-brain barrier to target plaques clogging up brain cells
Credit: Getty
Phase two trial results for trontinemab were presented at he Alzheimer's Association International Conference in Toronto.
Researchers said the drug seemed to clear plaques - the abnormal build-up of proteins around brain cells that cause damage and disrupt function - quicker than other drugs licensed to treat Alzheimer's.
Trontinemab cleared out plaques and eliminated visible signs of the the disease within 28 weeks for nine out of 10 patients.
Drug-maker Roche is now conducting another trial to see if plaque clearance also improves patients' memory.
The 18-month study includes 1,600 people, the Telegraph reported.
Separate research will examine whether the drug could be given to people without any signs of dementia, just as statins are used to ward off heart disease.
Experts hope the drug could stop patients from developing dementia symptoms at all, if it is given early enough.
They described the findings so far as 'very promising', suggesting that the drug was much more powerful than existing ones while leading to fewer side effects - as it was able to clear plaques better within seven months that other drugs can in 18 months.
Roche's chief medical officer Levi Garraway said: 'Alzheimer's disease represents one of the greatest challenges in healthcare today and tackling it requires early detection and effective therapeutics.
'Trontinemab is designed to target a key driver of Alzheimer's disease biology more effectively in the brain.
Common painkiller used for back pain ups risk of dementia by 29%, scientists warn
"Combining new treatment avenues with advanced diagnostics may enable earlier and potentially more effective intervention.
"With plans for phase three trials in both early symptomatic and pre-clinical Alzheimer's disease, we are advancing science with the goal of delaying - and ultimately preventing - progression of this devastating condition.'
Prof Sir John Hardy, the chairman of molecular biology of neurological disease at University College London's Institute of Neurology told the Telegraph trontinemab could be 'game-changing'.
The scientist, who was the first to identify the role of amyloid plaques in Alzeheimer's, said: 'This is absolutely great news.
"It sucks the plaque out of the brain really quickly, much faster than we have seen with lecanemab or donanemab.'
Both are Alzheimer's drugs approved for used in the UK, which target amyloid proteins in the brain to slow disease progression.
However, neither treatment is offered on the NHS, as the National Institute for Health and Care Excellence (Nice) deemed them too expensive - in large part because patients need frequent scans to monitor for brain swelling and bleeds.
Prof Hardy added: 'There is no doubt [trontinemab] could be game-changing.
"We hope that if we can use these drugs to people early, we can halt the progression of disease, even before people have symptoms.
"Now we need to see the size of the clinical effect.
'These results show it is much faster and safer than previous drugs, which means less monitoring.
"That brings down the cost significantly, it means fewer MRI scans, so that would surely mean it would get Nice approval.'
Early signs of dementia
It's not unusual for your memory to lapse a bit as you get older.
But dementia is different from 'just getting old' as it will cause noticeable - rather than gradual - changes to mental abilities and make managing everyday tasks and activities increasingly difficult.
The symptoms of dementia may be small to start with, but get worse over time.
Below are some examples of possible signs.
Memory loss
Memory loss is a key sign of dementia. This can include: Forgetting something you were only recently told. You may ask for the same information repeatedly – for example, 'Are the doors locked?'
Putting objects in unusual places – for example, putting your house keys in the refrigerator.
Being unable to learn new tasks, like how to use a new washing machine.
Planning and decision making issues
People with dementia can have difficulty with planning and decision making. This can include: Getting very confused when planning or thinking things through.
Struggling to stay focused on a single task.
Not making informed, careful decisions when dealing with money or looking at risks.
Finding it hard to manage regular payments, budgets or monthly bills.
Problems with language and understanding
In people with dementia, this can manifest as: Having frequent problems finding the right word or regularly referring to objects as 'that thing'.
Finding it hard to take part in conversations.
Regularly being unable to follow what someone is saying even without distractions.
Losing sense of time and place
Dementia can cause problems with orientation, including: Losing track of the date, season or the passage of time.
Getting lost in a place that is familiar or that should be easy to find your way around – for example, a supermarket.
Regularly being unable to follow what someone is saying even without distractions.
Problems with vision and perception
This can mean having problems making sense of what you see.
For example, having difficulty judging distances on stairs, or mistaking reflections or patterns for other objects.
Mood and behavioural changes
Finally, dementia can also make people act differently or shift their mood. This can mean: Becoming withdrawn and losing interest in work, friends or hobbies.
Feeling unusually sad, anxious, frightened or low in confidence.
Getting easily upset at home, at work, with friends or in places that usually feel comfortable or familiar.
Source: Alzheimer's Society
Trials for lecanemab and donanemab showed the drugs helped clear toxic clumps out of the brain and slow nerve damage caused by Alzheimer's by 27 per cent and 35 per cent respectively, over the course of 18 months.
But the treatments did present a risk of brain swelling and brain bleeds, meaning patients needed intense monitoring.
Trontinemab appears to be safer and cause fewer side effects, with less than five per cent of patients showing abnormal results on their brain scans.
All of these cases were quickly resolved, researchers said.
The drug - administered by infusion into the bloodstream - also doesn't need to be given a frequently.
Upcoming trials will examine the impact of giving the drug to patients once a month for six months, then every three months.
Trontinemab has been designed to efficiently bypass the blood-brain barrier, a protective layer of cells that stops harmful substances in the blood stream from attacking the brain and spinal cord.
This barrier can make it hard for many drugs to reach the brain.
Prof Jonathan Schott, the chief medical officer at Alzheimer's Research UK, told the Telegraph: 'We urgently need a range of treatments for Alzheimer's that are effective and safe for the people affected by this devastating disease.
'Evidence presented at the Alzheimer's Association conference in Toronto on trontinemab is very promising, showing that the drug can effectively and rapidly clear amyloid from the brain, seemingly with very few side effects.
'We now need to see whether these early stage results carry through to later stage clinical trials, which are planned to start later this year, including in the UK.
"These trials will show whether the drug is not only safe, but impacts on memory, thinking and quality of life.'
He said it was 'exciting' that the drug would now be tested in some people without symptoms under the phase three trials.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
an hour ago
- Scottish Sun
Fizzy drinks, ice cream and instant noodles could up your risk of LUNG cancer by 41%
Munching junk is especially bad news for both non-small cell lung cancer and the deadlier small cell type, experts say FOOD FOR THOUGHT Fizzy drinks, ice cream and instant noodles could up your risk of LUNG cancer by 41% Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SCOFFING fizzy drinks, ice cream and instant noodles could send your lung cancer risk soaring by 41 per cent, experts warn. A major study has found people who munch the most ultra-processed foods - or UPFs - are far more likely to get the disease than those who avoid them. Sign up for Scottish Sun newsletter Sign up 3 Fizzy drinks have been linked to lung cancer Credit: Getty Images - Getty 3 The findings don't prove ultra-processed foods cause cancer, rather that people should still try to cut down Credit: Getty An international team of scientists said junk food is particularly bad for non-small cell lung cancer and the more aggressive small cell type. Professor Sam Hare, consultant chest radiologist at the Royal Free London NHS Trust, said: 'A quarter of lung cancer cases occur in non-smokers so we do need research exploring whether other factors are associated with lung cancer." The study tracked the diets and health of more than 100,000 adults in the US over 12 years and found 1,706 went on to develop lung cancer. On average, people had nearly three servings of UPFs a day, but some had up to six. The favourites across diets were soft drinks and lunch meats. But the list also includes fried food, cakes, pastries, salty snacks, breakfast cereals, instant noodles and soups, margarine, sweets, burgers, hot dogs and pizza. Those who scoffed the most UPFs were 41 per cent more likely to get lung cancer than those who ate the least, according to findings in Thorax. The research team, tried to account for whether people smoked or not, but not how heavily, which could still skew the results. They warned the findings don't prove UPFs cause lung cancer, but said people should still try to cut down. They wrote: 'Although additional research in other populations and settings is warranted, these findings suggest the healthy benefits of limiting UPF. I'm a doctor and these 5 changes could be a sign of deadly lung cancer "Limiting trends of UPF intake globally could contribute to reducing the burden of lung cancer.' Prof Hare said further work was needed "to establish direct causation between UPFs and lung cancer". "Crucially, whilst the study does make some adjustments for smoking status, the amount of smoking is not factored in, which is known to be directly related to lung cancer development," he said. 'Dietary habits also change considerably over the course of such long-term studies. 3 Lung cancer symptoms usually only emerge as the disease develops "It's difficult to directly conclude that lung cancer is related to the level of UPF consumption alone given it was only declared at the start of the study. 'That said, given the relative lack of info on non-smoking risk factors for lung cancer, it's important that the scientific community does more studies like this – we need genuine evidence-based advancement in early diagnosis of lung cancer in non-smokers, but this study isn't quite able to give us the answers yet.' The findings come as a separate study looked at teenage smoking in the UK over 50 years. Experts from the University of Michigan tracked rates in 16 and 17-year-olds from 1974 to 2018, and found it had dropped from 33 per cent to 12 per cent. But in 2018, 11 per cent of older teens were vaping and those who did were far more likely to go on to smoke. Writing in Tobacco Control, the authors said just 1.5 per cent of non-vaping teens picked up cigarettes, compared to 33 per cent of vapers. 'Tobacco control efforts should continue to focus on the prevention of general youth nicotine use and to specifically target youth who use e-cigarettes because their risk of cigarette smoking is similar to youth in the 1970s,' they wrote. But some academics have slammed the findings, saying the conclusion is 'not justified'.
Daily Mail
4 hours ago
- Daily Mail
What is CTE? Doctors explain brain disorder New York shooter Shane Tamura claimed to have
The suspected shooter who killed four people in a Manhattan skyscraper Monday claimed to suffer from the brain disease Chronic Traumatic Encephalopathy, or CTE, which experts say could explain his violent behavior. Shane Tamura, 27, is accused of driving from Las Vegas to New York City, entering an office building that houses major financial firms and the National Football League and killing four people before shooting himself. In a suicide note Tamura reportedly had in his pocket, he criticized the NFL and claimed to suffer from CTE, which is most commonly seen in athletes who have suffered repeat concussions and brain injuries, causing permanent brain damage. Tamura was once a talented football player and his note, revealed by a source to CNN, stated: 'Terry Long football gave me CTE and it caused me to drink a gallon of antifreeze,' referring to the former NFL player who was diagnosed with CTE and died by suicide after drinking antifreeze in 2005. Authorities have also said Tamura, 27, had a 'documented mental health history' and in the car he was seen exiting before the shooting, they found cannabis and Zoloft, an antidepressant. Studies of American football players have revealed the consequences of repeated head trauma and traumatic brain injuries, including aggression, depression, impulsivity, psychosis, cognitive confusion, and premature death. However, the only way to diagnose CTE is by an autopsy after a person has died, so there is no way to know if the alleged shooter had the condition. Tamura's suicide note said he wanted his brain to be studied Dr Keith Vossel, a neurologist at the University of California, Los Angeles, told 'Often, criminality is not really common with most of the neurodegenerative diseases - criminality or homicidal or suicidal behaviors - but they can occur.' And while not all CTE sufferers will become homicidal or suicidal, those traits 'seem to be more common in the syndrome that we associate with CTE,' Dr Vossel added. Dr Vossel told this website: 'We're pretty sure that CTE is associated with impulsivity, sometimes suicidality, other mental health issues, due to strong association studies. 'It's really difficult to currently definitively prove the connection, but I think we're on the right track.' Dr Harrison Martland, a clinical pathologist, first named the condition 'punch drunk' in 1928, as it was more commonly seen in men who had entered and left the boxing arena multiple times. Since then, research and understanding of the condition have evolved. Doctors have determined that repeated blows to the head generate tau, a small protein found in brain cells that can break off and cause harmful tangles. But there is no test to screen for CTE in living patients, and symptoms often mimic those of Alzheimer's, PTSD, or Parkinson's. Tamura was a former high school football player who left a note in his pocket blaming his actions and mental health crisis on CTE. 'Study my brain please,' the note said. 'I'm sorry.' Dr Carole Lieberman, a board-certified psychiatrist, told 'What stands out in this case is how the NYC gunman chose to shoot himself in the chest rather than the head. 'This highly unusual decision suggests he wanted his brain preserved for autopsy, strongly indicating he believed he had CTE and wanted it confirmed.' To determine CTE in deceased brains researchers look for a buildup of tau in certain parts, including the frontal lobe, which plays a crucial role in problem-solving, self control, emotion regulation, impulsivity, and aggressive behavior. It is not known when, or if, an autopsy will be performed on Tamura. 'We know from other degenerative diseases like frontotemporal dementia that when the tau accumulates in regions that control our impulsivity and our social decorum… that can be associated with changes in personality and it can result in behaviors that can be disturbing for those around them,' Dr Vossel said. A 2024 study of nearly 2,000 former football players conducted by Harvard Medical School found that 34 percent think they have CTE, reporting more cognitive problems, depression, suicidal thoughts, chronic pain, and other issues not reported by people who did not believe they had CTE. Doctors have found that hundreds of football players have had CTE over the years. In 2023, the Boston University CTE Center announced that it posthumously diagnosed 345 former NFL players with chronic traumatic encephalopathy out of 376 retired players studied, equating to about 92 percent. Dr Vossel added that not all CTE sufferers become homicidal, but the disease does lead to major personality changes: 'Some people might start with more memory issues, and it's maybe a different rate of decline. 'It could be slower, and it could be older people, and they could look like they have Alzheimer's disease.' He continued: 'And then these more striking cases, the mental health issues tend to be occurring in younger people in whom it might be more difficult to disentangle any pre-existing mental health issue from CTE-related changes.' In the past, NFL athletes who have taken their own lives or those of others have been confirmed post-mortem to have had CTE. Several former players, including Dave Duerson and Junior Seau, died by suicide using firearms. Duerson and Seau intentionally shot themselves in the chest, like Tamura. Both former athletes were later diagnosed with CTE. Kansas City Chiefs linebacker Jovan Belcher shot and killed his girlfriend before driving to Arrowhead Stadium and taking his own life in front of his coach and general manager. According to a post-mortem report, Belcher's brain showed signs of CTE. And former New England Patriots player Aaron Hernandez was diagnosed with late-stage CTE after his 2017 suicide. He had been convicted of murder, having killed Odin Lloyd, a semi-pro football player, in 2015. In the final years, Hernandez became increasingly paranoid, convinced that people were out to kill him. Dr Lieberman said: 'The connection between neurological injury and sudden acts of violence should not be underestimated.' It is unclear whether Tamura suffered from symptoms linked to CTE, such as cognitive issues. And a post-mortem won't be able to detect if he also had a mental health condition, like depression, or separate any mental health issues he was contending with from symptoms, and consequences, of CTE. Dr Lieberman added: 'Clinical signs, such as mood instability, paranoia, aggression, and suicidal ideation, combined with a history of repeated head trauma, often point to it.
The Independent
5 hours ago
- The Independent
What is CTE? Condition claimed by Manhattan NFL skyscraper shooter that 1/3 of former players fear they have
Shane Tamura, the 27-year-old gunman who fatally shot 36-year-old New York City police officer Didarul Islam and several others in a New York City skyscraper on Monday, was reportedly found dead with a note claiming that football had given him chronic traumatic encephalopathy, or CTE. In it, he addressed former Pittsburgh Steelers player Terry Long, who was diagnosed with the neurodegenerative disease. Long drank a bottle of antifreeze to commit suicide in 2005, with doctors at the time attributing depression associated with the condition as a factor in his death. 'Terry Long, football gave me CTE and it caused me to drink a gallon of antifreeze,' the note said, according to reports from The New York Post. 'Please study brain for CTE. I'm sorry. The league knowingly concealed the dangers to our brains to maximize profits,' he wrote. 'They failed us.' On Tuesday, New York City Mayor Eric Adams told CNN that the city's medical examiner would determine the next steps for Tamura's body, including whether his brain would be tested for CTE. The mayor said earlier in the day that the attack was ' focused on the NFL, ' with the league confirming that one staffer had been hospitalized in the attack. But, what is CTE and how many people are affected? Here's what to know. What is CTE? CTE is a brain disorder that's been linked to repeated concussions and traumatic brain injuries. Symptoms include memory loss, problems with attention, mood disturbances, impaired judgment, poor muscle coordination, and suicidal thoughts, according to Harvard Medical School. While physical and speech therapy can be used to help, there is no way to reverse the symptons, which gets worse over time, according to the Mayo Clinic. However, the disease can only be diagnosed after death, using an autopsy. The exact number of Americans who have had CTE remains unknown. The connection to professional sports Heightened awareness about CTE has likely led athletes in high contact sports to retire sooner than they had planned. A study of nearly 2,000 former NFL players released last year found that one in three of those surveyed believe they have the degenerative brain disease CTE. Former New England Patriots star Aaron Hernandez, who died by suicide in a Massachusetts prison in 2017, was diagnosed with CTE after his death. Brett Favre, of the Green Bay Packers, has said he believes he may have CTE, as well. Boston University announced last year that 345 former NFL players, out of 376 who were studied, had been diagnosed with CTE. Tamura never featured in the NFL, but was a standout high school player, according to The LA Times. 'We know from conditions like Parkinson's and Alzheimer's, these neurodegenerative conditions that don't really have treatments or cures at the moment [and] that are really hard to diagnose, a lot of those conditions are associated with some suicidality and thoughts of self-harm,' Dr. Rachel Grashow, of the Harvard T. H. Chan School of Public Health, previously told The Independent. 'So, the final question we asked was, 'Do we see similar associations with our former players?' Similar research in former hockey players found that the odds of developing CTE increased by 34 percent with each year they played the sport. 'Ice hockey players with longer careers not only were more likely to have CTE, but they also had more severe disease,' Dr. Jesse Mez, the co-director of clinical research at Massachusetts' Boston University CTE Center, said in a statement. CTE has also been found in the brains of people who box, according to the Mayo Clinic, in rugby players, and military veterans. How do we prevent CTE? Increased research in this area aims to address the condition. Hundreds of brain donations from athletes have helped. Better-performing helmets have helped contribute to a 25 percent reduction in concussions across the last five NFL season, according to Harvard. If you are experiencing feelings of distress, or are struggling to cope, you can speak to the Samaritans, in confidence, on 116 123 (UK and ROI), email jo@ or visit the Samaritans website to find details of your nearest branch. If you are based in the USA, and you or someone you know needs mental health assistance right now, call the National Suicide Prevention Helpline on 1-800-273-TALK (8255). This is a free, confidential crisis hotline that is available to everyone 24 hours a day, seven days a week. If you are in another country, you can go to to find a helpline near you.
